These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 22500781)

  • 1. A review of augmentation therapy for alpha-1 antitrypsin deficiency.
    Mohanka M; Khemasuwan D; Stoller JK
    Expert Opin Biol Ther; 2012 Jun; 12(6):685-700. PubMed ID: 22500781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
    Franciosi AN; McCarthy C; McElvaney NG
    Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-1 antitrypsin augmentation therapy and biomarkers of elastin degradation.
    Ma S; Lin YY; He J; Rouhani FN; Brantly M; Turino GM
    COPD; 2013 Aug; 10(4):473-81. PubMed ID: 23560990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.
    Turner AM
    BioDrugs; 2013 Dec; 27(6):547-58. PubMed ID: 23771682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.
    Chorostowska-Wynimko J; Barrecheguren M; Ferrarotti I; Greulich T; Sandhaus RA; Campos M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():345-355. PubMed ID: 32103933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
    Tonelli AR; Brantly ML
    Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expert statement for augmentation therapy in patients with alpha-1 antitrypsin deficiency].
    Köhnlein T; Schmidt-Scherzer K; Greulich T; Bals R
    Pneumologie; 2014 Jul; 68(7):492-5. PubMed ID: 25006842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation therapy for alpha(1)-antitrypsin deficiency.
    Juvelekian GS; Stoller JK
    Drugs; 2004; 64(16):1743-56. PubMed ID: 15301559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding.
    Stoller JK; Aboussouan LS
    Thorax; 2004 Aug; 59(8):708-12. PubMed ID: 15282394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank.
    Tonelli AR; Rouhani F; Li N; Schreck P; Brantly ML
    Int J Chron Obstruct Pulmon Dis; 2009; 4():443-52. PubMed ID: 20054436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA; Lascano J
    Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
    O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG
    Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Heresi GA; Stoller JK
    Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
    McCarthy C; Reeves EP; McElvaney NG
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals.
    Hurley K; Lacey N; O'Dwyer CA; Bergin DA; McElvaney OJ; O'Brien ME; McElvaney OF; Reeves EP; McElvaney NG
    J Immunol; 2014 Oct; 193(8):3978-91. PubMed ID: 25217166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
    O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
    J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.